rosiglitazone has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palka, J; Szoka, L | 1 |
| Koeffler, HP; Maira, G; Mangiola, A; Mastrangelo, R; Mirabella, M; Morosetti, R; Rutella, S; Servidei, T | 1 |
2 other study(ies) available for rosiglitazone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Capsaicin up-regulates pro-apoptotic activity of thiazolidinediones in glioblastoma cell line.
Topics: Apoptosis; Brain Neoplasms; Capsaicin; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Glioblastoma; Humans; Ligands; Pioglitazone; PPAR gamma; Rosiglitazone; TRPV Cation Channels; Up-Regulation | 2020 |
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Topics: Apoptosis; Cell Differentiation; Cell Nucleus; Cell Proliferation; Cyclooxygenase 2; G2 Phase; Gene Expression; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Isoenzymes; Membrane Proteins; Neurofilament Proteins; PPAR gamma; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured; Up-Regulation; Vimentin | 2004 |